PET Studies in Epilepsy

dc.contributor.authorSarikaya, Ismet
dc.contributor.orcID0000-0002-1087-580Xen_US
dc.contributor.pubmedID26550535en_US
dc.contributor.researcherIDG-7881-2015en_US
dc.date.accessioned2024-03-12T12:41:13Z
dc.date.available2024-03-12T12:41:13Z
dc.date.issued2015
dc.description.abstractVarious PET studies, such as measurements of glucose, serotonin and oxygen metabolism, cerebral blood flow and receptor bindings are availabe for epilepsy. (18)Fluoro-2-deoxyglucose (F-18-FDG) PET imaging of brain glucose metabolism is a well established and widely available technique. Studies have demonstrated that the sensitivity of interictal FDG-PET is higher than interictal SPECT and similar to ictal SPECT for the lateralization and localization of epileptogenic foci in presurgical patients refractory to medical treatments who have noncontributory EEG and MRI. In addition to localizing epileptogenic focus, FDG-PET provide additional important information on the functional status of the rest of the brain. The main limitation of interictal FDG-PET is that it cannot precisely define the surgical margin as the area of hypometabolism usually extends beyond the epileptogenic zone. Various neurotransmitters (GABA, glutamate, opiates, serotonin, dopamine, acethylcholine, and adenosine) and receptor subtypes are involved in epilepsy. PET receptor imaging studies performed in limited centers help to understand the role of neurotransmitters in epileptogenesis, identify epileptic foci and investigate new treatment approaches. PET receptor imaging studies have demonstrated reduced C-11-flumazenil (GABAA-cBDZ) and F-18-MPPF (5-HT1A serotonin) and increased C-11-cerfentanil (mu opiate) and C-11-MeNTI (delta opiate) bindings in the area of seizure. 11C-flumazenil has been reported to be more sensitive than FDG-PET for identifying epileptic foci. The area of abnormality on GABAA-cBDZ and opiate receptor images is usually smaller and more circumscribed than the area of hypometabolism on FDG images. Studies have demonstrated that C-11-alpha-methyl-L-tryptophan PET (to study synthesis of serotonin) can detect the epileptic focus within malformations of cortical development and helps in differentiating epileptogenic from non-epileptogenic tubers in patients with tuberous sclerosis complex. O-15-H2O PET was reported to have a similar sensitivity to FDG-PET in detecting epileptic foci.en_US
dc.identifier.endpage430en_US
dc.identifier.issn2160-8407en_US
dc.identifier.issue5en_US
dc.identifier.startpage416en_US
dc.identifier.urihttp://hdl.handle.net/11727/11784
dc.identifier.volume5en_US
dc.identifier.wos000218921100001en_US
dc.language.isoengen_US
dc.relation.journalAMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPETen_US
dc.subjectEpilepsyen_US
dc.subjectFDGen_US
dc.subjectNeurotransmitteren_US
dc.subjectreceptoren_US
dc.titlePET Studies in Epilepsyen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: